SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-20-000038
Filing Date
2020-02-20
Accepted
2020-02-20 07:32:39
Documents
4
Period of Report
2020-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq1usindependentrevi.htm 8-K 19360
2 EXHIBIT 99.1 exh991-pressreleaseusindep.htm EX-99.1 11194
3 moleculin-logo_horiza22.jpg GRAPHIC 132868
4 moleculinlogoa31.jpg GRAPHIC 11658
  Complete submission text file 0001659617-20-000038.txt   220288
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 20632550
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences